Published in J Clin Invest on April 01, 1990
Phyllodes tumours. Postgrad Med J (2001) 2.75
Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul (1990) 1.08
Endothelin receptor A blockade enhances taxane effects in prostate cancer. Neoplasia (2006) 1.07
Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br J Cancer (1995) 1.01
Endothelin as an autocrine factor in the regulation of parathyroid cells. Proc Natl Acad Sci U S A (1991) 0.95
Stimulation of colorectal cancer cell line growth by ET-1 and its inhibition by ET(A) antagonists. Gut (2000) 0.94
Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer. Br J Cancer (1995) 0.90
Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts. Br J Cancer (1995) 0.84
Arginine vasopressin stimulates human mesangial cell production of endothelin. J Clin Invest (1991) 0.80
Two preproendothelin 1 mRNAs transcribed by alternative promoters. J Clin Invest (1993) 0.78
The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop. J Virol (1997) 0.75
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A (1988) 2.99
Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun (1989) 1.88
Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes. Biochem Biophys Res Commun (1988) 1.66
Epidermal growth factor-mediated activation of an S6 kinase in Swiss mouse 3T3 cells. J Biol Chem (1985) 1.65
Growth factor control of myoepithelial-cell differentiation in cultures of human mammary gland. Differentiation (1988) 1.47
Endothelin inhibits renin release from isolated rat glomeruli. Biochem Biophys Res Commun (1988) 1.36
Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun (1988) 1.32
Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem (1989) 1.23
Activation of phospholipase A2 by endothelin in cultured vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 1.18
Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension (1989) 1.05
Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol (1988) 3.88
Quantification of cells cultured on 96-well plates. Anal Biochem (1989) 2.66
Mutant p53 protein associated with chemosensitivity in breast cancer specimens. Lancet (1994) 2.29
The catalytic subunits of protein phosphatase-1 and protein phosphatase 2A are distinct gene products. Eur J Biochem (1984) 1.76
The NFkappaB pathway and endocrine-resistant breast cancer. Endocr Relat Cancer (2005) 1.76
Characterisation of a reconstituted Mg-ATP-dependent protein phosphatase. Eur J Biochem (1983) 1.58
Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res (1998) 1.57
Reconstitution of a Mg-ATP-dependent protein phosphatase and its activation through a phosphorylation mechanism. FEBS Lett (1982) 1.51
Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol (1992) 1.36
Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int J Cancer (2000) 1.35
Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest (1994) 1.33
Escherichia coli O157:H7 restriction pattern recognition by artificial neural network. J Clin Microbiol (1995) 1.30
Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem (1989) 1.23
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Activation of human peripheral monocytes by angiotensin II. FEBS Lett (1994) 1.16
Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells. J Biol Chem (1989) 1.15
Representation of clinical problem assessment phrases in U.S. family practice using Read version 3.1 terms: a preliminary study. Proc Annu Symp Comput Appl Med Care (1995) 1.14
Continuous synthesis of two protein-kinase-C-related proteins after down-regulation by phorbol esters. Proc Natl Acad Sci U S A (1988) 1.10
Immunological quantitation of phospholipid/Ca2+-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors. Int J Cancer (1987) 1.10
Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul (1990) 1.08
The vasodilator potency of atrial natriuretic peptide in man. Circulation (1987) 1.07
Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.05
Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension (1989) 1.05
Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res (1992) 1.04
Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun (1990) 1.04
The 27,000 daltons stress proteins are phosphorylated by protein kinase C during the tumor promoter-mediated growth inhibition of human mammary carcinoma cells. Biochem Biophys Res Commun (1988) 1.04
Agrin can mediate acetylcholine receptor gene expression in muscle by aggregation of muscle-derived neuregulins. J Cell Biol (1998) 1.03
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Isolation and characterization of a toxic lipid-protein complex formed in mouse skin by controlled thermal energy. Comparison to an inactive precursor derived from thermally unexposed or native skin. Biochim Biophys Acta (1972) 1.02
Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer (1994) 1.02
Isolation, biological and antigenic properties of a specific toxin formed in thermally altered mouse skin. Eur J Clin Invest (1972) 1.01
Comparing clinical vocabularies using coding system fidelity. Proc Annu Symp Comput Appl Med Care (1995) 1.01
Histamine-induced phosphoinositide metabolism in cultured human umbilical vein endothelial cells. Association with thromboxane and prostacyclin release. Biochem Biophys Res Commun (1987) 1.00
Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. Int J Cancer (1993) 0.99
Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension (1992) 0.98
Cardiac Arrest in Canine Practice. Can J Comp Med Vet Sci (1961) 0.97
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay. J Clin Oncol (2001) 0.95
Predictive value of EGF receptor in breast cancer. Lancet (1988) 0.95
Biphasic Ca2+ response of adenylate cyclase. The role of calmodulin in its activation by Ca2+ ions. Eur J Biochem (1986) 0.95
Getting around in a large nomenclature file: browsing SNOMED international. Proc Annu Symp Comput Appl Med Care (1994) 0.94
Lactic acidosis: a factor associated with equine laminitis. J Anim Sci (1977) 0.94
Equine laminitis of alimentary origin: an experimental model. Am J Vet Res (1975) 0.93
Amino acid sequence at the site on protein phosphatase inhibitor-2, phosphorylated by glycogen synthase kinase-3. Biochim Biophys Acta (1984) 0.92
Indirect blood pressure measurement in the dog. Lab Anim Sci (1975) 0.92
Molecular and cellular biology of endothelin and its receptors--Part II. J Hypertens (1993) 0.91
Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res (1986) 0.90
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
Retinoic acid-binding protein in human breast cancer and dysplasia. J Natl Cancer Inst (1978) 0.88
Functional aspects of vascular tenascin-C expression. J Vasc Res (1995) 0.88
Extracellular matrix: differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats. J Cell Physiol (1989) 0.88
The adhesion of glow--discharge polymers, Silastic and Parylene to implantable platinum electrodes: results of tensile pull tests after exposure to isotonic sodium chloride. Biomaterials (1981) 0.88
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells. Cardiovasc Res (2001) 0.87
Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol (1990) 0.87
Effects of halothane and isoflurane on mean arterial blood pressure, heart rate, and respiratory rate in adult Pekin ducks. Am J Vet Res (1990) 0.87
Evidence for the identity of nuclear and cytoplasmic adenosine-3':5'-monophosphate-dependent protein kinase from porcine ovaries and nuclear translocation of the cytoplasmic enzyme. Eur J Biochem (1977) 0.87
Stimulation of autocrine platelet--derived growth factor AA-homodimer and transforming growth factor beta in vascular smooth muscle cells. Biochem Biophys Res Commun (1991) 0.86
Cyclic AMP-dependent protein kinase type I and type II and cyclic AMP binding in human mammary tumors. Adv Cyclic Nucleotide Res (1980) 0.86
Vascular smooth muscle cell calcium fluxes. Regulation by angiotensin II and lipoproteins. Hypertension (1993) 0.86
Phorbol ester and epidermal growth factor receptors in human breast cancer. Anticancer Res (1987) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Tumour necrosis factor and interferon are selectively cytostatic in vitro for hormone-dependent and hormone-independent human breast cancer cells. Eur J Cancer (1996) 0.86
Equine laminitis and associated hypertension: a review. J Am Vet Med Assoc (1975) 0.85
PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J Cell Biochem (1997) 0.85
Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells. Biochem Biophys Res Commun (1986) 0.85
Subcellular distribution of protein kinase C of GH3 cells: quantitation and characterization by polyacrylamide gel electrophoresis. Arch Biochem Biophys (1985) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
Induction of thrombospondin expression in vascular smooth muscle cells by angiotensin II. J Cardiovasc Pharmacol (1990) 0.84
Increased cardiac myosin ATPase activity as a biochemical adaptation to running training: enhanced response to catecholamines and a role for myosin phosphorylation. J Mol Cell Cardiol (1981) 0.84
Role of extracellular electrolytes in the activation of ribosomal protein S6 kinase by epidermal growth factor, insulin-like growth factor 1, and insulin in ZR-75-1 cells. J Cell Biol (1988) 0.84
Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin. FEBS Lett (1998) 0.84
Quantitative estimation of cellular retinoic acid-binding protein activity in normal, dysplastic, and neoplastic human breast tissue. Cancer Res (1980) 0.84
BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer. Swiss Med Wkly (2001) 0.84
A World Wide Web accessible multi-species ECG database. Biomed Sci Instrum (1997) 0.84
Effects of tumor promoters on growth and on cellular redistribution of phospholipid/Ca2+-dependent protein kinase in human breast cancer cells. Int J Cancer (1986) 0.83
Altered cellular ratio of type I and type II cyclic AMP-dependent protein kinase in human mammary tumors. FEBS Lett (1979) 0.83
Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7. J Natl Cancer Inst (1983) 0.83
Computerized medical records--new opportunities. Mo Med (1993) 0.83
Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscler Thromb (1993) 0.83
The cytosolic phorboid receptor correlates with hormone dependency in six mammary carcinoma cell lines. Biochem Biophys Res Commun (1985) 0.83
Dephosphorylation of myofibrillar proteins in actomyosin preparations and in isolated perfused rat hearts after beta-agonist withdrawal. J Mol Cell Cardiol (1982) 0.83
Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function. Eur J Biochem (1986) 0.83
A yeast-based bioassay for the determination of functional and non-functional estrogen receptors. Nucleic Acids Res (1999) 0.82
Dependence of urokinase-type-plasminogen-activator induction on cyclic AMP-dependent protein kinase activation in LLC-PK1 cells. Biochem J (1987) 0.82
T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo. Br J Dermatol (2010) 0.82
Translocation of protein kinase C is not required to inhibit the antigen-induced increase of cytosolic calcium in a mast cell line. Biochem Biophys Res Commun (1987) 0.82
A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol (1982) 0.82
Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue. FEBS Lett (1977) 0.82
The dual role of mutant p53 protein in chemosensitivity of human cancers. Anticancer Res (1997) 0.82
Differential stimulation of growth related metabolism in cultured smooth muscle cells from SHR and WKY rats by combinations of EGF and LDL. Biochem Biophys Res Commun (1989) 0.82
Simultaneous quantitative detection of relevant biomarkers in breast cancer by quantitative real-time PCR. Int J Biol Markers (2006) 0.82
Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol (1994) 0.81
Protein kinases and proteins binding adenosine 3':5'-monophosphate in subcellular fractions of calf ovaries. Effect of trypsin and protease inhibitors on protein kinases. Eur J Biochem (1977) 0.81
Bringing a WEB-based interface to a hospital information system. Biomed Sci Instrum (1997) 0.81
Castration and other factors affecting the risk of equine laminitis. Cornell Vet (1975) 0.81